Ortogrupė, UAB - financials and debts

Company age: 8 y. 2 mo.

Update

Ortogrupė - Company finances

EUR
2018
From: 2018-07-31
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 19,009 347,709 399,703 354,596 752,853 930,583 1,249,923 1,056,697
Profit before tax -20,380 478 45,015 7,132 145,348 170,705 236,306 244,772
Net profit -20,380 406 40,870 5,917 124,506 144,378 201,329 207,464
Equity -17,880 1,129 21,999 27,916 130,422 228,800 257,573 299,155
Liabilities 60,262 165,851 208,956 205,613 264,765 330,417 390,722 460,685
Non-current assets 443 11,436 12,118 11,630 64,213 95,932 173,828 187,433
Current assets 41,939 155,544 218,837 221,899 330,974 463,285 474,218 572,297
Total assets 42,382 166,980 230,955 233,529 395,187 559,217 648,046 759,730
Taxes paid
STI taxes - - - - - 149,422 231,037 149,144
Social insurance contributions - - - - - - - 11,797
Financial indicators
Revenue change y/y - +1729.2% +15.0% -11.3% +112.3% +23.6% +34.3% -15.5%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -48.1% 0.2% 17.7% 2.5% 31.5% 25.8% 31.1% 27.3%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - 36.0% 185.8% 21.2% 95.5% 63.1% 78.2% 69.4%
Profit margin Net profit margin. Shows the overall profitability of the company. -107.2% 0.1% 10.2% 1.7% 16.5% 15.5% 16.1% 19.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -107.2% 0.1% 11.3% 2.0% 19.3% 18.3% 18.9% 23.2%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 146.9 9.5 7.4 2.0 1.4 1.5 1.5
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 7,920 115,903 133,234 118,199 250,951 310,194 416,641 314,157

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Ortogrupė - Social security debts

From To Debt, €
2026-04-20 2026-04-22 88.21
2026-02-04 2026-02-04 1.10
2024-05-16 2024-05-16 387.14

Ortogrupė - VMI tax arrears

From To Overdue, €
2026-01-08 2026-01-12 2327.94
2025-08-15 2025-08-19 2.44
2025-08-14 2025-08-14 97.56
2025-08-01 2025-08-13 2.44
2025-07-28 2025-07-31 2.16
2025-07-22 2025-07-23 1031.16
2025-07-19 2025-07-21 1018.16
2025-06-19 2025-07-18 0.16
2025-05-10 2025-05-13 306.23
2025-04-28 2025-05-09 5.0
2025-02-28 2025-03-12 0.12
2025-02-23 2025-02-24 79.08
2025-02-20 2025-02-22 79.0
2025-02-14 2025-02-14 111.04
2025-02-13 2025-02-13 110.77
2025-01-14 2025-01-14 681.72

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Ortogrupe, UAB (company code 304887887) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the latest financial year, revenue amounted to €1.06M and net profit reached €207.5K, with a profit margin of 19.6%. Revenue decreased by 15.5% year on year from €1.25M in 2024, but profitability remained solid and net profit still increased slightly from €201.3K. Over the three-year period, revenue rose from €930.6K in 2023 to €1.25M in 2024 and then moderated in 2025, while net profit increased from €144.4K to €201.3K and then to €207.5K. At year-end 2025, total assets stood at €759.7K, equity at €299.2K and liabilities at €460.7K. The equity ratio was 39.4% and debt-to-equity 1.54. Asset turnover was 1.39x, ROE 69.3% and ROA 27.3%. Revenue per employee was €352.2K, indicating strong productivity.